Neoplasia, cancer and late effects

ea0038p145 | Neoplasia, cancer and late effects

Nicotinamide nucleotide transhydrogenase (NNT) as a novel molecular target in adrenocortical carcinoma – impact of NNT knockdown on adrenocortical cell proliferation, redox balance and steroidogenesis

ea0038p146 | Neoplasia, cancer and late effects

The somatostatin analogue pasireotide decreased proliferation and increased apoptosis in pancreatic and pituitary neuroendocrine tumors in a MEN1 mouse model

ea0038p147 | Neoplasia, cancer and late effects

Steroid sulphatase and G-protein coupled oestrogen receptor in human colorectal cancer: correlation with late-stage disease and potential therapeutic targets

ea0038p148 | Neoplasia, cancer and late effects

PTTG is phosphorylated at residue T60 and regulates p53 stability, in conjunction with PBF, in head and neck cancer

ea0038p149 | Neoplasia, cancer and late effects

Distinct p53 response profiles in transgenic mouse models of thyroid-specific PBF and PTTG expression

ea0038p150 | Neoplasia, cancer and late effects

Follow up of differentiated thyroid cancer survivors during pregnancy: a retrospective analysis

ea0038p151 | Neoplasia, cancer and late effects

Pituitary-related outcomes of cranial radiotherapy (cXRT) in adults with gliomas

ea0038p152 | Neoplasia, cancer and late effects

Phenotypic heterogeneity associated with proglucagon-expressing tumours is due to differential processing and secretion of proglucagon-derived peptides

ea0038p153 | Neoplasia, cancer and late effects

Novel targeted treatment combinations for malignant neuroendocrine tumour olfactory neuroblastoma

ea0038p154 | Neoplasia, cancer and late effects

Adrenal pigmentation in PPNAD is a result of melanin deposition and associated with upregulation of the melanocortin 1 receptor

ea0038p155 | Neoplasia, cancer and late effects

Primary cilia: a new player in phaeochromocytoma pathogenesis?

ea0038p156 | Neoplasia, cancer and late effects

Adverse metabolic profile in long-term survivors of adult and childhood-onset brain tumours: the role of growth hormone deficiency

ea0038p157 | Neoplasia, cancer and late effects

Ultrasound-guided percutaneous ethanol ablation for selected patients with papillary thyroid microcarcinoma: a novel, effective and well tolerated alternative to neck surgery or observation

ea0038p158 | Neoplasia, cancer and late effects

Clot structure analysis in survivors of acute lymphoblastic leukaemia: the role of growth hormone deficiency

ea0038p159 | Neoplasia, cancer and late effects

Use of Sunitinib in refractory hypercalcaemia in pancreatic neuroendocrine tumours

ea0038p160 | Neoplasia, cancer and late effects

Metastatic paraganglioma with isolated 3-methoxytyramine rise in a patient with SDHC mutation

ea0038p164 | Neoplasia, cancer and late effects

Recurrent phaeochromocytomas in type2C variant of Von Hippel-Lindau syndrome

ea0038p165 | Neoplasia, cancer and late effects

Lutetium ablation therapy as treatment for recurrent metastatic bladder paraganglioma

ea0038p166 | Neoplasia, cancer and late effects

Somatostatin responsive ACTH and precursor excess in a midgut mesentery NET

ea0038p167 | Neoplasia, cancer and late effects

Primary adrenal lymphoma

ea0038p168 | Neoplasia, cancer and late effects

Metastatic bowel carcinoid associated bilateral carcinoid heart disease

ea0038p169 | Neoplasia, cancer and late effects

Familial insulinoma in the absence of MEN

ea0038p170 | Neoplasia, cancer and late effects

A young girl with bilateral adrenal tumours

ea0038p171 | Neoplasia, cancer and late effects

Acromegaly in association with a bronchial carcinoid tumour

ea0038p172 | Neoplasia, cancer and late effects

Challenges in the diagnosis and management of a case of glucagonoma first presenting as a localised genital rash

ea0038p173 | Neoplasia, cancer and late effects

A management dilemma – emergency treatment of primary hyperparathyroidism in suspected but unconfirmed multiple endocrine neoplasia type 1

ea0038p174 | Neoplasia, cancer and late effects

Promoter methylation signatures of BRCA2 and TP53 genes in the serum of some breast cancer patients attending radiotherapy clinic in Lagos, Nigeria

ea0038p175 | Neoplasia, cancer and late effects

Endocrine Abstracts

Society for Endocrinology BES 2015

Poster Presentations

Nicotinamide nucleotide transhydrogenase (NNT) as a novel molecular target in adrenocortical carcinoma – impact of NNT knockdown on adrenocortical cell proliferation, redox balance and steroidogenesis

The somatostatin analogue pasireotide decreased proliferation and increased apoptosis in pancreatic and pituitary neuroendocrine tumors in a MEN1 mouse model

Steroid sulphatase and G-protein coupled oestrogen receptor in human colorectal cancer: correlation with late-stage disease and potential therapeutic targets

PTTG is phosphorylated at residue T60 and regulates p53 stability, in conjunction with PBF, in head and neck cancer

Distinct p53 response profiles in transgenic mouse models of thyroid-specific PBF and PTTG expression

Follow up of differentiated thyroid cancer survivors during pregnancy: a retrospective analysis

Pituitary-related outcomes of cranial radiotherapy (cXRT) in adults with gliomas

Phenotypic heterogeneity associated with proglucagon-expressing tumours is due to differential processing and secretion of proglucagon-derived peptides

Novel targeted treatment combinations for malignant neuroendocrine tumour olfactory neuroblastoma

Adrenal pigmentation in PPNAD is a result of melanin deposition and associated with upregulation of the melanocortin 1 receptor

Primary cilia: a new player in phaeochromocytoma pathogenesis?

Adverse metabolic profile in long-term survivors of adult and childhood-onset brain tumours: the role of growth hormone deficiency

Ultrasound-guided percutaneous ethanol ablation for selected patients with papillary thyroid microcarcinoma: a novel, effective and well tolerated alternative to neck surgery or observation

Clot structure analysis in survivors of acute lymphoblastic leukaemia: the role of growth hormone deficiency

Use of Sunitinib in refractory hypercalcaemia in pancreatic neuroendocrine tumours

Chromogranin B: a possible prognostic biomarker for neuroendocrine tumours?

Imaging and evaluating side effects of antiandrogen therapy

Outcome of insulinomas diagnosed in a tertiary endocrine centre

Metastatic paraganglioma with isolated 3-methoxytyramine rise in a patient with SDHC mutation

Recurrent phaeochromocytomas in type2C variant of Von Hippel-Lindau syndrome

Lutetium ablation therapy as treatment for recurrent metastatic bladder paraganglioma

Somatostatin responsive ACTH and precursor excess in a midgut mesentery NET

Primary adrenal lymphoma

Metastatic bowel carcinoid associated bilateral carcinoid heart disease

Familial insulinoma in the absence of MEN

A young girl with bilateral adrenal tumours

Acromegaly in association with a bronchial carcinoid tumour

Challenges in the diagnosis and management of a case of glucagonoma first presenting as a localised genital rash

A management dilemma – emergency treatment of primary hyperparathyroidism in suspected but unconfirmed multiple endocrine neoplasia type 1

Promoter methylation signatures of BRCA2 and TP53 genes in the serum of some breast cancer patients attending radiotherapy clinic in Lagos, Nigeria

Confusion in a patient with carcinoid syndrome

BiosciAbstracts